Researchers uncover genetic variants linked to Parkinson’s disease in Iceland

Researchers at Icelandic genetic research firm DeCODE have discovered rare genetic variants that increase the likelihood of developing Parkinson’s disease. This finding may pave the way for new drug development, according to the investigators.

A study detailing their research was published today in the journal NPJ Parkinson’s Disease. The identified genetic variants reduce the activity of a protein believed to be involved in the disease’s pathogenesis. By focusing on this protein and its signaling pathways, there is potential for developing innovative treatments for Parkinson’s disease.

This discovery adds to the growing understanding of the genetic factors that contribute to Parkinson’s, highlighting the importance of genetic research in unraveling complex diseases.